Logo image
300‐Hz subthalamic oscillations in Parkinson’s disease
Journal article   Open access   Peer reviewed

300‐Hz subthalamic oscillations in Parkinson’s disease

G. Foffani, A. Priori, M. Egidi, P. Rampini, F. Tamma, E. Caputo, K. A. Moxon, S. Cerutti and S. Barbieri
Brain (London, England : 1878), v 126(10), pp 2153-2163
Oct 2003
PMID: 12937087
url
https://doi.org/10.1093/brain/awg229View
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze) Open

Abstract

DBS = deep brain stimulation deep brain stimulation ERS = event‐related synchronization event‐related synchronization high frequency levodopa LFP = local field potential SN = substantia nigra STN = subthalamic nucleus subthalamus UPDRS = unified Parkinson’s disease rating scale
Despite several studies and models, much remains unclear about how the human basal ganglia operate. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an effective treatment for complicated Parkinson’s disease, but how DBS acts also remains unknown. The clinical benefit of DBS at frequencies >100 Hz suggests the possible importance of neural rhythms operating at frequencies higher than the range normally considered for basal ganglia processing (<100 Hz). The electrodes implanted for DBS also offer the opportunity to record neural activity from the human basal ganglia. This study aimed to assess whether oscillations at frequencies >100 Hz operate in the human STN. While recording local field potentials from the STN of nine patients with Parkinson’s disease through DBS electrodes, we found a dopamine‐ and movement‐dependent 300‐Hz rhythm. At rest, and in the absence of dopaminergic medication, in most cases (eight out of 11 nuclei) the 100–1000 Hz band showed no consistent rhythm. Levodopa administration elicited (or markedly increased) a 300‐Hz rhythm at rest [(mean ± SD) central frequency: 319 ± 33 Hz; bandwidth: 72 ± 21 Hz; power increase (after medication – before medication)/before medication: 1.30 ± 1.25; n = 11, P = 0.00098]. The 300‐Hz rhythm was also increased by apomorphine, but not by orphenadrine. The 300‐Hz rhythm was modulated by voluntary movement. Before levodopa administration, movement‐related power increase in the 300‐Hz rhythm was variably present in different subjects, whereas after levodopa it became a robust phenomenon [before 0.014 ± 0.014 arbitrary units (AU), after 0.178 ± 0.339 AU; n = 8, P = 0.0078]. The dopamine‐dependent 300‐Hz rhythm probably reflects a bistable compound nuclear activity and supports high‐resolution information processing in the basal ganglia circuit. An absent 300‐Hz subthalamic rhythm could be a pathophysiological clue in Parkinson’s disease. The 300‐Hz rhythm also provides the rationale for an excitatory—and not only inhibitory—interpretation of DBS mechanism of action in humans.

Metrics

13 Record Views
201 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Clinical Neurology
Neurosciences
Logo image